In vitro irritation models and immune reactions

Area of Science:

• Dermatology
• Toxicology
• In Vitro Models

Background:

• Irritant contact dermatitis stems from direct skin injury by chemicals.
• European regulations mandate strict ingredient screening, driving demand for alternatives to animal testing.
• Ethical concerns and legislation (Cosmetics Directive, REACH) promote the development of non-animal testing methods.

Purpose of the Study:

• To review current in vitro skin irritation models.
• To describe biomarkers used for assessing irritancy.
• To highlight advancements in toxicological assessment of substances.

Main Methods:

• Description of four in vitro models: submerged cultures (keratinocytes, fibroblasts), epidermal equivalents, skin equivalents, and fresh skin.
• Review of biomarkers including cytokines (IL-1α, IL-6, IL-8), PGE2, SKALP, HSP70, kinases.
• Assessment of metabolic activity (MTT assay) and cytosolic leakage (lactate dehydrogenase assay).

Main Results:

• Various in vitro models and biomarkers are available for skin irritation assessment.
• Established methods include cell-based assays measuring metabolic activity and cell damage.
• Genomic and proteomic studies are underutilized but hold potential for novel biomarker discovery.

Conclusions:

• In vitro models offer viable alternatives to animal testing for evaluating skin irritancy.
• Biomarker analysis provides quantitative measures of irritant effects.
• Further research into omics approaches could enhance understanding and identification of new biomarkers for irritant contact dermatitis.